Natural History of Radiation Papillopathy after Proton Beam Irradiation of Parapapillary Melanoma

被引:34
作者
Kim, Ivana K. [1 ]
Lane, Anne Marie [1 ]
Egan, Kathleen M. [2 ]
Munzenrider, John [3 ]
Gragoudas, Evangelos S. [1 ]
机构
[1] Harvard Univ, Sch Med, Retina Serv, Massachusetts Eye & Ear Infirm,Dept Ophthalmol, Boston, MA 02114 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Div Populat Sci, Tampa, FL 33682 USA
[3] Harvard Univ, Sch Med, Dept Radiat Oncol, Massachusetts Gen Hosp, Boston, MA USA
关键词
INDUCED OPTIC NEUROPATHY; HYPERBARIC-OXYGEN THERAPY; CHOROIDAL MELANOMA; PLAQUE RADIOTHERAPY; VISUAL-LOSS;
D O I
10.1016/j.ophtha.2009.12.015
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the natural history of radiation papillopathy after proton beam irradiation of parapapillary choroidal melanoma. Design: Noncomparative case series. Participants: Ninety-three eyes of 93 patients. Methods: Retrospective chart review of patients with choroidal melanoma within 0 to 1 disc diameter (DD) of the optic nerve and at least 2 DD away from the fovea treated with proton beam irradiation. Main Outcome Measures: Rates of papillopathy, visual loss, and visual improvement. Results: Sixty-eight percent of patients developed papillopathy a median of 1.5 years (17.7 months) after radiation. Among patients who developed papillopathy, 5-year rates of vision retention were 42% for counting fingers or better and 23% for 20/200 or better. At 5 years after the onset of papillopathy, 31% of patients had spontaneous visual improvement of 3 or more lines compared with the time of papillopathy diagnosis. Conclusions: Even in eyes receiving high doses of radiation to the optic nerve for treatment of intraocular tumors, approximately two thirds of patients develop radiation papillopathy. After the development of papillopathy, 42% of eyes retain useful vision and one third of eyes have significant spontaneous visual improvement over 5 years. The natural history of radiation papillopathy may be more favorable than previously assumed, and therefore treatments for this condition must be compared with an appropriate control group. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references. Ophthalmology 2010; 117: 1617-1622 (C) 2010 by the American Academy of Ophthalmology.
引用
收藏
页码:1617 / 1622
页数:6
相关论文
共 18 条
[1]   Inefficiency of the anticoagulant therapy in the regression of the radiation-induced optic neuropathy in Cushing's disease [J].
Barbosa, AP ;
Carvalho, D ;
Marques, L ;
Monteiro, M ;
Neves, AC ;
Carvalho, AM ;
Cruz, J ;
Medina, JL .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1999, 22 (04) :301-305
[2]  
Bartsch Helmut, 2007, V174, P19
[3]   Radiation optic neuropathy: Report of cases, role of hyperbaric oxygen therapy, and literature review [J].
Borruat, FX ;
Schatz, NJ ;
Glaser, JS ;
Matos, L ;
Feuer, W .
NEURO-OPHTHALMOLOGY, 1996, 16 (04) :255-266
[4]  
BORRUAT FX, 1993, J CLIN NEURO-OPHTHAL, V13, P98
[5]  
BROWN GC, 1982, OPHTHALMOLOGY, V89, P1489
[6]   Visual loss despite anticoagulation in radiation-induced optic neuropathy [J].
Danesh-Meyer, HV ;
Savino, PJ ;
Sergott, RC .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 32 (03) :333-335
[7]   Plaque radiotherapy for juxtapapillary choroidal melanoma - Visual acuity and survival outcome [J].
DePotter, P ;
Shields, CL ;
Shields, JA ;
Cater, JR ;
Brady, LW .
ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (11) :1357-1365
[8]   Anti-VEGF bevacizumab (Avastin®) for radiation optic neuropathy [J].
Finger, Paul T. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (02) :335-338
[9]   Radiation optic neuropathy after stereotactic radiosurgery [J].
Girkin, CA ;
Comey, CH ;
Lunsford, LD ;
Goodman, ML ;
Kline, LB .
OPHTHALMOLOGY, 1997, 104 (10) :1634-1643
[10]  
GRAGOUDAS ES, 1987, OPHTHALMOLOGY, V94, P349